Replay available

Eurofins Scientific Sa (ERFSF) Q4 2025 Earnings Call

Eurofins Scientific Sa (OTC: ERFSF) Q4 2025 earnings conference call, held 2026-01-29. Replay captured from the company's public earnings webcast.

Thu, January 29, 2026 at 9:00 AMendedReplay
Eurofins Scientific Sa (ERFSF) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Dr. Gilles Martin

CEO, Eurofins

Tom Burlton

Analyst, BNP Paribas

Delphine Lalouet

Analyst, Bernstein

Suhasini Varanasi

Analyst, Goldman Sachs

Replay transcript excerpt

Thank you for holding. We look forward to talking with you soon. Please hold the line and we'll be right back with you. Thanks for holding. We appreciate your time and patience. Please stay on the line, and we'll be back in just a moment. Thank you for holding. We sincerely appreciate your patience. Please stay on the line, and we'll be back in a moment. Ladies and gentlemen, welcome and thank you for joining Eurofins 2025 full year results. Please note that this call is being recorded and will later be available for replay on the Eurofins Investor Relations website. Throughout today's presentation, all participants will be in a listen-only mode. The presentation will be followed by a question and answer session. If you would like to ask a question, you may press star followed by one on your touchtone telephone to register for questions. For operator assistance, please press the star key followed by zero. During this call, Eurofins management may make forward-looking statements, including but not limited to statements with respect to outlook and the related assumptions. Management will also discuss alternative performance measures, such as organic growth and EBITDA, which are defined in the footnotes of our press releases. Actual results may differ materially from objectives discussed. Risks and uncertainties that may affect Eurofins' future results include, but are not limited to, those described in the risk factors section of the most recent Eurofins annual and half-year reports. Please also read the disclaimer on page two of this presentation, subject to which this call and Q&A session are made. I would now like to turn the conference over to Dr. Gilles Martin, Eurofins CEO. Please go ahead. Thank you, Andrew. Hello, everybody, and thank you for joining our full-y...

More from Eurofins Scientific Se